148 related articles for article (PubMed ID: 1071824)
1. The therapy of obesity and anorectics.
Andrle B; Strnad L
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1976; 19(1):7-12. PubMed ID: 1071824
[No Abstract] [Full Text] [Related]
2. Obesity.
Arterburn D
Clin Evid; 2002 Jun; (7):538-47. PubMed ID: 12230679
[No Abstract] [Full Text] [Related]
3. Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome.
Georgopoulos NA; Katsikis I; Florakis D; Panidis D; Kandarakis ED
Fertil Steril; 2009 Jun; 91(6):e1. PubMed ID: 19362719
[No Abstract] [Full Text] [Related]
4. Obesity.
Arterburn D
Clin Evid; 2002 Dec; (8):587-601. PubMed ID: 12603901
[No Abstract] [Full Text] [Related]
5. [Clinical evaluation of a new anorexigenic agent].
Marrón JA; Arrieta F; Herrera JL
Rev Clin Esp; 1970 Jul; 118(2):159-64. PubMed ID: 5486373
[No Abstract] [Full Text] [Related]
6. [Studies with the new appetite depressant Aminorex-Fumarat (Menocil) in patients with internal diseases].
Hotz HW
Praxis; 1967 Nov; 56(45):1538-40. PubMed ID: 5632025
[No Abstract] [Full Text] [Related]
7. [Results of treatment of obesity with low calorie diet and additional drugs (author's transl)].
Komarnicka R; Gorzko M
Przegl Lek; 1975; 32(11):814-7. PubMed ID: 1215566
[No Abstract] [Full Text] [Related]
8. [Therapeutic and iatrogenic weight loss].
Codaccioni JL; Fontaine G; Rossi D
Rev Prat; 1982 Jan; 32(3):273-81. PubMed ID: 7071487
[No Abstract] [Full Text] [Related]
9. [Therapeutic trial of an anorectic agent using the double blind cross-over technic].
Bienert HR; Uberla K
Arzneimittelforschung; 1967 Mar; 17(3):336-42. PubMed ID: 4869817
[No Abstract] [Full Text] [Related]
10. [Drug information for nurses. Obesity; therapeutic main group: anorectics, appetite depressants. 4. Treatment of obesity].
Lumholtz IB
Sygeplejersken; 1976 Oct; 76(42):17. PubMed ID: 1050130
[No Abstract] [Full Text] [Related]
11. [Human pharmacology of anorectics. Validity of a questionnaire on appetite].
Gagnon MA; Tétreault L
Union Med Can; 1975 Jun; 104(6):922-9. PubMed ID: 1224411
[No Abstract] [Full Text] [Related]
12. Anti-lipaemic effect of Desopimon in obesity and in diabetes mellitus accompanied by obesity.
Less E
Ther Hung; 1974; 22(1):27-31. PubMed ID: 4844928
[No Abstract] [Full Text] [Related]
13. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties.
Elliott BW
Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837
[No Abstract] [Full Text] [Related]
14. [The importance of the biguanides in the treatment of obesity].
Bittnerová H; Masek J; Rath R
Z Gesamte Inn Med; 1969 Mar; 24(5):139-42. PubMed ID: 5785830
[No Abstract] [Full Text] [Related]
15. [Therapy of obesity with "Redukal"].
Ziegler A
Dtsch Gesundheitsw; 1971 Jul; 26(27):1247-51. PubMed ID: 5093314
[No Abstract] [Full Text] [Related]
16. [Treatment of obesity: are anorectics effective?].
Thissen JP
J Pharm Belg; 1996; 51(4):226. PubMed ID: 8965254
[No Abstract] [Full Text] [Related]
17. [Ambulatory treatment of obesity].
Nogaller AM; Nekliudova EP
Sov Med; 1975 Jun; (6):111-4. PubMed ID: 1162449
[No Abstract] [Full Text] [Related]
18. [Leptin and obesity: is the use of this hormone the solution to this illness?].
González-Barranco J
Rev Invest Clin; 2000; 52(2):113-4. PubMed ID: 10846432
[No Abstract] [Full Text] [Related]
19. Appetite-suppressant drugs in the management of obesity: the current view.
Silverstone T
Int J Obes; 1987; 11 Suppl 3():135-9. PubMed ID: 3440686
[No Abstract] [Full Text] [Related]
20. [Drug information for nurses. Obesity; therapeutic main group: anorectics, appetite depressants. 2. Causes in the development of obesity].
Lumholtz IB
Sygeplejersken; 1976 Sep; 76(38):13. PubMed ID: 1050110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
